← Back to Search

Botanical Preparation

Myalgesin for Osteoarthritis

Phase 3
Waitlist Available
Led By Stuart I Erner, MD
Research Sponsored by ProThera, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

This trial tests Myalgesin, a natural supplement made from celery seeds, Boswellia resin, and Phellodendron bark. It aims to help people with knee osteoarthritis by reducing inflammation and blocking enzymes that cause pain, thereby improving joint function and mobility.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MyalgesinExperimental Treatment1 Intervention
Subjects receive Myalgesin twice daily
Group II: AcetaminophenActive Control1 Intervention
Subjects receive acetaminophen 1000 mg three times a day

Find a Location

Who is running the clinical trial?

ProThera, Inc.Lead Sponsor
Stuart I Erner, MDPrincipal InvestigatorPrivate Practice
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top